Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data FRACTYL HEALTH, INC. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2024
FY2024
FY2025
Revenue
0.12
0.09
0
Cost of revenue
0.08
0.05
0
Gross profit
0.04
0.04
0
Research and development
38
70.5
74.5
Selling, general and administrative
12.8
23.1
22.3
Operating expenses
50.9
93.6
96.8
Operating income
-50.8
-93.5
-96.8
Interest income
1.26
4.15
1.54
Other non-operating income
-26.3
24.8
-44.1
Income tax
0
0
0
Net income
-77.1
-68.7
-141
EBITDA
-50.6
-92.9
-95.7
EPS, basic
-45.29
-1.62
-1.86
EPS, diluted
-45.29
-1.62
-1.86
Shares, basic (weighted)
2.08
43.5
75.8
Shares, diluted (weighted)
2.08
43.5
75.8
Balance sheet
FY2024
FY2024
FY2025
Cash and equivalents
33.2
67.5
81.5
Receivables
0.02
0
Inventory
0.07
0.07
Other current assets
6.04
Total current assets
35.6
71.8
87.6
Property, plant and equipment
0.49
2.98
2.41
Lease right-of-use assets
30.3
28.4
26.8
Other non-current assets
5.54
0.67
0.34
Total assets
76.2
108
121
Accounts payable
0.55
3.24
1.57
Total current liabilities
11.2
19.8
18.3
Long-term debt
55.2
30.2
30.6
Lease liabilities
28.5
27.4
26
Other non-current liabilities
1
0.66
Total liabilities
114
79.7
112
Paid-in capital
21.6
444
566
Retained earnings
-347
-415
-556
Shareholders' equity
-325
28.4
9.46
Total equity
-325
28.4
9.46
Total liabilities and equity
76.2
108
121
Shares outstanding
2.11
48.8
153
Cash flow statement
FY2024
FY2024
FY2025
Net income
-77.1
-68.7
-141
Depreciation and amortization
0.29
0.68
1.13
Stock-based compensation
4.3
14.4
6.68
Change in receivables
-0.02
0.02
Change in inventory
-0.07
0.07
Change in payables
-0.43
2.69
-1.67
Cash from operations
-42.8
-65.5
-90.3
Capital expenditures
-0.36
-1.77
-0.56
Cash from investing
-0.36
-1.77
-0.56
Stock issued
0.05
0.57
6.78
Cash from financing
27.4
101
105
Net change in cash
-15.7
33.9
14.1
Free cash flow
-43.2
-67.3
-90.9
Interest paid
0.76
3.13
4.3
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.49 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Return on assets (ROA)
-128.9%
Net income / average total assets.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-100.0%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
-100.0%
Gross profit vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
-66.7%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
12.3%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
74.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
3.15x
Current assets / current liabilities.
Quick ratio
3.00x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
3.00x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Operating cash flow per share
-$0.52
Cash from operations / diluted weighted shares.
Book value per share
-$0.01
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
Earnings yield
-136.7%
Net income / market cap (the inverse of P/E).
What was FRACTYL HEALTH, INC.'s revenue in fiscal 2025?
FRACTYL HEALTH, INC. reported revenue of $0.0 for fiscal 2025, 100% lower than the year before.
Was FRACTYL HEALTH, INC. profitable in fiscal 2025?
No. It reported a net loss of $141.0M.
How much free cash flow did FRACTYL HEALTH, INC. generate in fiscal 2025?
Cash from operations of $90.3M minus capital expenditures of $557.0K left free cash flow of -$90.9M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.